Funding Received
$9.8 Million in 2 Rounds from 7 Investors
Most Recent Funding
$4.3 Million on October 1, 2005 / Undisclosed Round
Headquarters:
Zürich
Description:
Kuros Biosurgery develops biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine.
Founders:
Prof. Jeffrey A. Hubbell
Categories:
Biotechnology
Website:
http://www.kuros.ch

Detailed Description

Update

Kuros Biosurgery is a biotechnology company dedicated to developing biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine. Kuros products are based on two different matrix technologies that allow the attachment of biologics or drugs and that can be applied locally.

Current Team (1)

Update

Past Team (1)

Update

Board Members and Advisors (2)

Update

Investors (7)

Update
  • 2d84c3e2500a731f69cb42d7b5b9f56f

    VI Partners

    Swiss venture capital firm
  • 113937c7afa25822ea1cbdca6c400186

    VINCI CAPITAL

    Swiss PE firm
  • 2cdb3322ab4f8af452b09f37549d3ca7

    DEFI Gestion

    DEFI Gestion SA has close to CHF 200 million in assets under management, for institutional as...
  • 398246d677f54cdbb9e2cb197bf32d9b

    Genevest Consulting Group

    Genevest provides advisory services for institutional and sophisticated high net worth investors...
  • E8ab3db273e0e2f681c45f0e11fb54e7

    CDC Enterprises

    CDC Enterprises is a French Government (French treasury) owned €150 million fund of funds, that...
  • 8a9c1f8dbc0675a61cfa7c59319d29f1

    NeoMed

    International venture capital investment
  • Wdfw6pktvwbvpmg5i7bd

    Innovation Capital

    international venture capital firm

Offices/Locations (1)

Update
  • Office

    Technoparkstrasse 1

    Zürich, CH-8005

    CHE

Images (1)

Update
  • C48f1c694161fb05148d926a8d9861bc